Emmessar Biotech & Nutrition Ltd. is requesting an extension of time to hold their board meeting for the quarter ended September 30, 2023, and is seeking a waiver of penalties for any potential delay in submitting the financial results and corporate governance certificate. They are explaining that the delay is due to the need to schedule an Extraordinary General Meeting (EGM) for the appointment of Statutory Auditors.